Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study

Correction to: Trials (2020) 21:80

https://doi.org/10.1186/s13063-019-3965-4

After publication of our article [1] the authors have notified us that one of the names has been incorrectly spelled.

  • Original name spelling:

    Charlotte Flühe

  • Correct name spelling:

    Charlotte Flüh

The original article has been corrected.

Reference

  1. 1.

    Tegtmeier, et al. Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study. Trials. 2020;21:80. https://doi.org/10.1186/s13063-019-3965-4.

Download references

Author information

Correspondence to Reinhard Schinzel.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tegtmeier, F., Schinzel, R., Beer, R. et al. Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study. Trials 21, 172 (2020). https://doi.org/10.1186/s13063-020-4107-8

Download citation